Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

August 28, 2018

Primary Completion Date

October 19, 2019

Study Completion Date

October 19, 2019

Conditions
Fetal Agenesis of the Corpus Callosum (ACC)
Interventions
GENETIC

whole exome sequencing (WES)

"WES analysis will be performed in the UF de Génomique du Développement (APHP, Pitié-Salpêtrière hospital), using DNA extracted from amniotic fluid for the foetus (also used for chromosomal studies) and DNA extracted from peripheral blood for both parents. There will be no supplemental invasive sampling for this study. The result of WES will be returned during a consultation with the geneticist and the associated prognosis will be explained in case of molecular diagnosis"

Trial Locations (1)

75013

Groupe Hospitalier Pitié-Salpêtrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03600792 - Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum | Biotech Hunter | Biotech Hunter